Funding and Licensing Opportunities and Challenges for Biopharma in APAC, Upcoming Webinar Hosted by Xtalks PRWeb FacebookTwitterEmail In this free webinar, the featured speaker will discuss how to mitigate the challenges faced by APAC biotechs seeking to gain access to US/EU investors and partners. Attendees will understand how to maximize potential interest from outside investors in APAC markets and how to strengthen the case for valuation and market potential of assets. TORONTO (PRWEB) March 01, 2021 The biopharmaceutical industry is rapidly expanding all over the world. Traditional markets such as the United States and Europe continue to lead much of the industry, but it is becoming impossible to ignore the explosive growth in the Asia and Pacific (APAC) region, driven largely by countries like China, India and Japan. While venture capital investment may have slowed overall in the face of the pandemic, this was not so in APAC. In Chinese biotech alone, for example, the first half of 2020 saw 95 biotech deals, worth $12 billion: an unprecedented amount of activity.